Cumberland Pharmaceuticals, Inc. (CPIX)

[surf1944]

5) Cumberland Pharmaceuticals, Inc. (CPIX)
Sector: Healthcare
Industry: Drug Manufacturers - Other
Market Cap: $127.71M
Beta: -

Cumberland Pharmaceuticals, Inc. has a Current Ratio of 14.01, a Quick Ratio of 13.03, and a 1-Year Projected Earnings Per Share Growth Rate of 38.24%. The short interest was 9.31% as of 07/01/2012. Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. The company's principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It is also developing Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome.

*Company profiles were sourced from Finviz. Financial data was sourced from Google Finance and Yahoo Finance.

http://seekingalpha.com/article/695761-5-high-growth-healthcare-small-caps-armed-with-cash?source=yahoo